1
/
of
1
Elabscience
SKU:E-CL-R0740
Rat GFAP(Glial Fibrillary Acidic Protein) CLIA Kit
Rat GFAP(Glial Fibrillary Acidic Protein) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Rat GFAP (Glial Fibrillary Acidic Protein) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of GFAP levels in rat samples. This high-quality kit is meticulously crafted to meet the demands of researchers and scientists in the field of neuroscience.
The Rat GFAP CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and reliable method for quantifying GFAP levels. With its advanced technology, this kit ensures precise and reproducible results, enabling researchers to obtain valuable insights into the role of GFAP in various neurological disorders and conditions.
Featuring a comprehensive set of components, the Rat GFAP CLIA Kit offers a streamlined workflow, simplifying the experimental process. The kit includes all necessary reagents, standards, and controls, ensuring convenience and accuracy throughout the assay. Additionally, the kit provides a wide dynamic range, allowing for the detection of GFAP levels across a broad spectrum of concentrations.
The Rat GFAP CLIA Kit is designed to deliver exceptional performance, exhibiting excellent sensitivity and specificity. Its robust design minimizes interference from other substances, guaranteeing reliable and precise measurements. Moreover, this kit boasts a rapid assay time, enabling researchers to obtain results in a time-efficient manner.
With its user-friendly protocol and comprehensive manual, the Rat GFAP CLIA Kit is suitable for both experienced researchers and newcomers to the field. The kit's intuitive design and clear instructions ensure ease of use and minimize the potential for errors, enhancing the overall efficiency of experiments.
In summary, the Rat GFAP CLIA Kit is a state-of-the-art solution that empowers researchers to explore the intricate world of GFAP in rat samples. Its exceptional sensitivity, reliability, and user-friendly features make it an indispensable tool for advancing our understanding of neurological disorders and paving the way for innovative therapeutic interventions.
The Rat GFAP CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and reliable method for quantifying GFAP levels. With its advanced technology, this kit ensures precise and reproducible results, enabling researchers to obtain valuable insights into the role of GFAP in various neurological disorders and conditions.
Featuring a comprehensive set of components, the Rat GFAP CLIA Kit offers a streamlined workflow, simplifying the experimental process. The kit includes all necessary reagents, standards, and controls, ensuring convenience and accuracy throughout the assay. Additionally, the kit provides a wide dynamic range, allowing for the detection of GFAP levels across a broad spectrum of concentrations.
The Rat GFAP CLIA Kit is designed to deliver exceptional performance, exhibiting excellent sensitivity and specificity. Its robust design minimizes interference from other substances, guaranteeing reliable and precise measurements. Moreover, this kit boasts a rapid assay time, enabling researchers to obtain results in a time-efficient manner.
With its user-friendly protocol and comprehensive manual, the Rat GFAP CLIA Kit is suitable for both experienced researchers and newcomers to the field. The kit's intuitive design and clear instructions ensure ease of use and minimize the potential for errors, enhancing the overall efficiency of experiments.
In summary, the Rat GFAP CLIA Kit is a state-of-the-art solution that empowers researchers to explore the intricate world of GFAP in rat samples. Its exceptional sensitivity, reliability, and user-friendly features make it an indispensable tool for advancing our understanding of neurological disorders and paving the way for innovative therapeutic interventions.
Share
